ResearcherUniversity of Campania "Luigi Vanvitelli"Active in the last 2 years
Rosaria Benedetti
Matched on ORCID iD 0000-0001-5517-5519; OpenAlex author ID A5009160904, A5110967102. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41392-025-02546-8↗
- Targeting the Tumor-Stroma Crosstalk: An AI-Based Virtual Screening Strategy for Dual MET/SMO Inhibitors in Pancreatic Cancer Co-author DOI 10.64898/2026.07.03.736313↗
- Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14153799↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ugo Chianese · 3 shared papers, 2022–2026 · strength 0.62
- Paper Targeting the Tumor-Stroma Crosstalk: An AI-Based Virtual Screening Strategy for Dual MET/SMO Inhibitors in Pancreatic … DOI 10.64898/2026.07.03.736313↗
- Paper Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma. DOI 10.1038/s41392-025-02546-8↗
- Paper Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14153799↗
- Stefania Scala · 1 shared paper, 2026 · strength 0.24
- Fortunato Ciardiello · 1 shared paper, 2026 · strength 0.24
- Sandro Cosconati · 1 shared paper, 2026 · strength 0.24
- Floriana Morgillo · 1 shared paper, 2026 · strength 0.24
- Crescenzo D’Alterio · 1 shared paper, 2026 · strength 0.24
- Michele Roggia · 1 shared paper, 2026 · strength 0.24
- Enza Lonardo · 1 shared paper, 2026 · strength 0.23
- Ferdinando De Vita · 1 shared paper, 2026 · strength 0.23
- Ahmad Hassan Ali · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.